- Home
- APLS vs ETY Comparison
APLS vs ETY Comparison
Compare APLS & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ETY
- Stock Information
- Founded
- APLS 2009
- ETY 2006
- Country
- APLS United States
- ETY United States
- Employees
- APLS N/A
- ETY N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ETY Finance Companies
- Sector
- APLS Health Care
- ETY Finance
- Exchange
- APLS Nasdaq
- ETY Nasdaq
- Market Cap
- APLS 2.3B
- ETY 2.1B
- IPO Year
- APLS 2017
- ETY N/A
- Fundamental
- Price
- APLS $17.30
- ETY $14.26
- Analyst Decision
- APLS Buy
- ETY
- Analyst Count
- APLS 19
- ETY 0
- Target Price
- APLS $39.06
- ETY N/A
- AVG Volume (30 Days)
- APLS 2.7M
- ETY 247.3K
- Earning Date
- APLS 05-07-2025
- ETY 01-01-0001
- Dividend Yield
- APLS N/A
- ETY 7.21%
- EPS Growth
- APLS N/A
- ETY N/A
- EPS
- APLS N/A
- ETY N/A
- Revenue
- APLS $775,839,000.00
- ETY N/A
- Revenue This Year
- APLS $12.25
- ETY N/A
- Revenue Next Year
- APLS $21.08
- ETY N/A
- P/E Ratio
- APLS N/A
- ETY N/A
- Revenue Growth
- APLS 48.04
- ETY N/A
- 52 Week Low
- APLS $16.65
- ETY $10.59
- 52 Week High
- APLS $43.99
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- APLS 34.14
- ETY 58.79
- Support Level
- APLS $16.65
- ETY $13.99
- Resistance Level
- APLS $20.75
- ETY $14.37
- Average True Range (ATR)
- APLS 1.09
- ETY 0.25
- MACD
- APLS 0.14
- ETY 0.12
- Stochastic Oscillator
- APLS 15.85
- ETY 92.99
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.